Labcor无支架带瓣肺动脉管道用于右室流出道重建的中期结果
本研究回顾性分析53例先天性心脏病患者使用Labcor管道行右室流出道重建的中期结果,中位随访4.6年,无院内死亡,5年免于管道失败率为80.5%,管道中位寿命7.4年,较小管道尺寸和较低年龄与管道失败相关。
要点
- Labcor管道中期结果可接受,多数患者术后5年内功能良好。
- 5年免于管道失败率为80.5%,狭窄是失败主因。
- 较小管道尺寸和较低年龄与管道失败相关。
核心结论
- Labcor管道用于右室流出道重建的中期结果可接受,多数患者术后5年内功能足够良好。
研究设计与样本
- 回顾性分析2009年2月至2016年7月53例植入Labcor管道的患者,分析围术期数据、免于管道失败率和管道功能障碍危险因素。
主要发现
- 最常见诊断为法洛四联症(n=20,37.7%),手术中位年龄10.0岁(IQR 4.9-14.3)。
- 无院内死亡,中位随访4.6年(IQR 3.4-5.6),14例(27.5%)发生管道失败,狭窄为主要原因。
- 2年免于管道失败率为98.0%,5年为80.5%,管道中位寿命7.4年(95%CI 5.1-9.8)。
- 较低年龄和较小管道尺寸与管道失败相关。
关键数值与推荐
- 管道中位尺寸21 mm(范围11-25 mm)。
- 肺动脉成形37例(69.8%),右室流出道加宽16例(30.2%)。
临床怎么用
- Labcor管道可作为右室流出道重建的同种移植物替代选择,术后5年内多数功能良好。
- 对小尺寸管道和低龄患者需加强随访,警惕管道失败。
局限性
- 样本量较小(53例),为单中心回顾性分析。
- 随访时间有限,管道退化和长期结局仍需进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The right ventricular outflow tract reconstruction is a common necessity in congenital cardiac surgery. As homograft availability is limited, alternatives need to be evaluated. The Labcor® conduit consists of a porcine tricomposite valve assembled inside a bovine pericardium tube. This study presents intermediate-term results for its utilization for right ventricular outflow tract reconstruction. METHODS: Labcor conduits were implanted in 53 patients (February 2009-July 2016). We analysed perioperative data, freedom from conduit failure and risk factors for conduit dysfunction. RESULTS: The most common diagnosis was Tetralogy of Fallot (n = 20, 37.7%). The median age at surgery was 10.0 [interquartile range (IQR) 4.9-14.3] years. Pulmonary artery plasty (n = 37, 69.8%) and augmentation of the right ventricular outflow tract (n = 16, 30.2%) were often part of the procedure. The median conduit size was 21 (range 11-25) mm. There was no in-hospital death. The median follow-up after surgery was 4.6 (IQR 3.4-5.6) years. Fourteen patients (27.5%) developed conduit failure with stenosis being the main cause. Freedom from conduit failure was 98.0% at 2 and 80.5% at 5 years. The median longevity of the conduit was 7.4 years (95% confidence interval 5.1-9.8 years). Younger age and smaller conduit size were related to conduit failure. CONCLUSIONS: Utilization of the Labcor conduit revealed acceptable intermediate-term results. The conduit appeared to be functioning sufficiently well within the first 5 years in the majority of patients. The higher rate of failure concerning smaller conduits might be associated with somatic outgrowth; however, conduit degeneration as common and long-term outcome still needs to be evaluated.
引用
- Jussli-Melchers J, Scheewe J, Hansen JH, et al. Right ventricular outflow tract reconstruction with the Labcor® stentless valved pulmonary conduit. Eur J Cardiothorac Surg. 2020. PMID: 31302680. doi:10.1093/ejcts/ezz200
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。